Health
First made-in-India smart solution for diabetes
Wellthy Therapeutics has designed a 16-week structured diabetes management programme to be delivered through a mobile app. The the first-of-its-kind trial was launched in India in the current month by Past President of RSSDI, Dr. Sarita Bajaj at the RSSDI Annual Conference in Bhubaneswar. Under this programme, dedicated health coaches will provide personalized diabetes self-management education and real time coaching with the support of an artificial intelligence powered chat bot. It will improve the health of patients with type2 diabetes and engage with them for behavioral change. Mr. Abhishek Shah, Co-founder and CEO of Wellthy Therapeutics said that the Wellthy app has been found to be effective in various pilot studies. Dr. Rajeev Chawla, Current President Elect of RSSDI opines, “The need for digital interventions in diabetes care is more now than ever, especially in India. The Wellthy Diabetes intervention is an innovation born out of India, for Indians and South Asians. This clinical trial holds tremendous potential in terms of changing outcomes for persons living with diabetes, by making it easier for them to manage their blood sugar levels and improving their overall quality of life.”
|